Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 40 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Cytarabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2017

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Research - peer-reviewArticle

temozolomide
Acute Myeloid Leukemia
Poly(ADP-ribose) Polymerase Inhibitors
veliparib
Methylation

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E. Feb 15 2017 In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Research - peer-reviewArticle

Leukemia, Myelomonocytic, Chronic
Topotecan
Carboplatin
Leukemia
Neoplasms

Assessment of drug sensitivity in hematopoietic stem and progenitor cells from acute myelogenous leukemia and myelodysplastic syndrome ex vivo

Knorr, K. L. B., Finn, L. E., Douglas Smith, B., Hess, A. D., Foran, J. M., Karp, J. E. & Kaufmann, S. H. Mar 1 2017 In : Stem Cells Translational Medicine. 6, 3, p. 840-850 11 p.

Research output: Research - peer-reviewArticle

Myelodysplastic Syndromes
Hematopoietic Stem Cells
Acute Myeloid Leukemia
Stem Cells
Pharmaceutical Preparations

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Kayser, S. , Krzykalla, J. , Elliott, M. A. , Norsworthy, K. , Gonzales, P. , Hills, R. K. , Baer, M. R. , Ráčil, Z. , Mayer, J. , Novak, J. , Žák, P. , Szotkowski, T. , Grimwade, D. , Russell, N. H. , Walter, R. B. , Estey, E. H. , Westermann, J. , Görner, M. , Benner, A. , Krämer, A. & 10 others Smith, B. D., Burnett, A. K., Thiede, C., Röllig, C., Ho, A. D., Ehninger, G., Schlenk, R. F., Tallman, M. S., Levis, M. J. & Platzbecker, U. Apr 18 2017 (Accepted/In press) In : Leukemia.

Research output: Research - peer-reviewArticle

Acute Promyelocytic Leukemia
Tretinoin
Therapeutics
arsenic trioxide
Recurrence
Graft vs Host Disease
Cyclophosphamide
Transplantation
Recurrence
Bone Marrow